Qiagen N.V. (QGEN) News
NYSE: QGENHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
45.38+0.85 (+1.91%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
QGEN news summary
We found 2 recent headlines mentioning Qiagen N.V. (QGEN): 0 in the past week and 2 in the past 30 days, most often from Nasdaq. For price context, QGEN is up 1.91% at $45.38. The most recent story, "Friday's ETF with Unusual Volume: HTEC", was published by Nasdaq on Oct 2, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Qiagen N.V. headlines
- Friday's ETF with Unusual Volume: HTECThe ROBO Global Healthcare Technology and Innovation ETF is seeing unusually high volume in afternoon trading Friday, with over 454,000 shares traded versus three month average volume of about…NasdaqHTEC, BSX, MRNA, QGEN
- QIAGEN Expands US QIAstat-Dx Portfolio With New FDA-Cleared PanelQGEN expands its U.S. QIAstat-Dx portfolio with an FDA-cleared panel that detects gram-negative bacteria and resistance markers in about one hour.NasdaqQGEN, BDX, TMO, BRKR